{
    "clinical_study": {
        "@rank": "43474", 
        "arm_group": [
            {
                "arm_group_label": "PRN injection of aflibercept", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravitreal aflibercept"
            }, 
            {
                "arm_group_label": "Two months injection of aflibercept", 
                "arm_group_type": "Active Comparator", 
                "description": "Intravitreal afilibercept"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial\n      monthly intravitreal aflibercept for the Japanese age related macular degeneration."
        }, 
        "brief_title": "Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Age-related Macular Degeneration", 
        "condition_browse": {
            "mesh_term": "Macular Degeneration"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of age-related macular degeneration\n\n        Exclusion Criteria:\n\n          -  Any treatment before intravitreal Aflibercept for age-related macular degeneration.\n\n          -  Visual acuity above 0.1 in decimal visual acuity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01824225", 
            "org_study_id": "NihonU-2"
        }, 
        "intervention": {
            "arm_group_label": [
                "PRN injection of aflibercept", 
                "Two months injection of aflibercept"
            ], 
            "intervention_name": "Aflibercept", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "aflibercept", 
            "intravitreal injection"
        ], 
        "lastchanged_date": "April 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chiyoda-ku", 
                    "country": "Japan", 
                    "state": "Tokyo", 
                    "zip": "101-8309"
                }, 
                "name": "Surugadai Nihon university hospital"
            }
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration", 
        "overall_official": {
            "affiliation": "Surugadai Nihon University Hospital", 
            "last_name": "Mitsuko Yuzawa, M.D.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Visual acuity after treatment by PRN or 2 months intravitreal Aflibercept", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01824225"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Nihon University", 
            "investigator_full_name": "Koji Tanaka", 
            "investigator_title": "Lecturer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Nihon University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nihon University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}